$5.520
-0.040 (-0.72%)終値時点
TVGN の同業比較
In the context of the broader market, TVGN competes directly with industry leaders such as SCYX and VERU. With a market capitalization of $35.94M, it holds a significant position in the sector. When comparing efficiency, TVGN's gross margin of N/A stands against SCYX's N/A and VERU's N/A. Such benchmarking helps identify whether Tevogen Inc is trading at a premium or discount relative to its financial performance.
Tevogen Bio Holdings Inc の財務パフォーマンス
Tevogen Bio has reported no revenue for several quarters, with a net income of -5,583,776 in Q2 2026. The current ratio is low at 0.33, indicating potential liquidity issues.
Financials
FY2026Q2
0.00
Total Revenue
FY2026Q2
YoY:
+4.00%
-5.66M
Operating Profit
FY2026Q2
YoY:
+4.69%
-5.76M
Net Income after Tax
FY2026Q2
YoY:
-0.65%
-1.52
EPS - Diluted
FY2026Q2
YoY:
-5.78%
-3.00M
Free Cash Flow
関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。